Stem cells, exosomes, gene therapy, peptides, hyperbaric oxygen, and epigenetic reprogramming
390 articoli
Clinical trial investigated whether pressurized oxygen treatments could stimulate new blood vessel growth in elderly participants.
Austrian researchers tracked heart attack patients for 5 years after receiving bone marrow cell therapy to assess long-term cardiac outcomes.
65-patient trial tested bone marrow stem cells injected directly into damaged heart muscle to restore function in chronic heart failure.
Study evaluates umbilical cord and placental tissues for cost-effective mesenchymal stem cell banking and regenerative medicine applications.
Small trial tests autologous stem cells to regenerate damaged knee cartilage in osteoarthritis patients with promising safety profile.
150-person trial tests whether PRP injections can reduce knee pain and improve function better than placebo in osteoarthritis patients.
Comprehensive review of emerging single-cell technologies that simultaneously analyze DNA, RNA, and proteins from individual cells, revolutionizing cancer diagnosis and treatment.
New CRISPR-Cas12a control methods enable safer, more targeted gene editing with reduced off-target effects and improved precision.
CRISPR gene editing successfully prevented heart failure in mice by disabling a key protein that drives cardiac damage.
Systematic review reveals hyperbaric oxygen therapy improved bone density and strength through multiple biological pathways in rats.
New delivery system combines stem cell vesicles with hydrogels to cross blood-brain barrier and treat neurological disorders.
New scaffolding systems deliver healing exosomes to stubborn wounds like diabetic ulcers, offering hope beyond conventional treatments.
